News - Generics, Global

Filter

Current filters:

GenericsGlobal

Popular Filters

1 to 25 of 61 results

European generics group welcomes WHA resolution on biotherapeutics products

04-06-2014

The European Generic Medicines Association (EGA) has welcomed the 67th World Health Assembly’s Resolution…

BiosimilarsGenericsGlobalRegulation

EGA calls for international regulatory cooperation

03-06-2014

European Generics Medicines Association (EGA) Director General Adrian van den Hoven last week joined…

GenericsGlobalPharmaceutical industryRegulationResearch

Prosonix and Mylan in deal for Flixotide and Flovent generics

15-04-2014

Prosonix, a UK-based company which is developing a portfolio of inhaled “Respiratory Medicines by Design,”…

FloventGenericsGlaxoSmithKlineGlobalLicensingMylan LaboratoriesProsonixRespiratory and Pulmonary

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards

03-07-2013

From July 2, 2013, all active substances manufactured outside of the European Union and imported into…

EuropeGenericsGlobalPharmaceuticalProductionRegulation

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30-05-2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData

10-05-2013

The rising prices of new cancer drugs are resulting in an increasing cost burden for patients and health…

BiotechnologyGenericsGlobalMarkets & MarketingOncologyPharmaceuticalPricing

Global biosimilar drug revenues will reach $2,445 million in 2013, says Visiongain

08-05-2013

The world market for biosimilar drugs will be worth $2,445 million in 2013, growing by more than 20%…

BiotechnologyCellTrionGenericsGlobalHospiraMarkets & MarketingSandoz

Pfenex and Agila Biotech set up JV to develop biosimilars

16-04-2013

US biotech firm Pfenex Inc. and Agila Biotech, a subsidiary of Indian drugmaker Strides Arcolab (BO:…

Agila BiotechBayerBetaferonBetaseronBiotechnologyGenericsGlobalNeurologicalPfenexProductionResearchStrides Arcolab

Support for introduction of a global regulatory process for biosimilars

16-04-2013

The majority of surveyed US and European physicians and payers are in favor of the introduction of a…

BiotechnologyGenericsGlobalRegulationResearch

GlaxoSmithKline and A*STAR's ICES to develop medicines for emerging markets

09-04-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and Singapore-based A*STAR's Institute of Chemical and Engineering…

GenericsGlaxoSmithKlineGlobalPharmaceuticalResearch

CNS therapeutics market facing downward pressure as branded drugs continue to expire

08-04-2013

The global central nervous system (CNS) therapeutics market has been forecast to reach $133 billion by…

GenericsGlobalMarkets & MarketingNeurologicalPharmaceutical

Medicines Patent Pool and ViiV Healthcare collaborate to treat pediatric HIV

28-02-2013

The Medicines Patent Pool (MPP) this week announced the launch of a new collaboration with ViiV Healthcare…

AbacavirAnti-viralsGenericsGlobalPatentsPharmaceuticalViiV Healthcare

India to expand presence in global generics market

12-02-2013

India plans to significantly expand its presence in the global generics market during the next several…

GenericsGlobalMarkets & Marketing

Generic statins to slash global market value by 2018

30-01-2013

The introduction of generic statins has kick-started a decline that will see the global statins market…

Cardio-vascularGenericsGlobalMarkets & Marketing

Sales of antiretroviral agents for HIV will decline slightly over next decade

18-12-2012

Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

Major constraints in the hospital-treated infections drug market include generic erosion

06-12-2012

The hospital-treated infections (HTI) drug market, the loss of patent protection for key branded products…

Antibiotics and Infectious diseasesGenericsGlobalMarkets & MarketingPharmaceuticalResearch

Big Pharma embraces biologics

21-11-2012

Fast-evolving biopharmaceuticals will challenge synthetic market dominance in the global market for active…

BiotechnologyGenericsGlobalMarkets & Marketing

Generic drugs market will reach $127.8 billion in 2013, Visiongain predicts

20-11-2012

The value of the world prescription generic drug industry stands at $110.8 billion in 2011 and is forecast…

GenericsGlobalMarkets & MarketingPatents

Migraine drug sales to grow to $5.8 billion in 2021 in major markets

18-11-2012

Despite a decline in sales owing to the generic entry of most triptans, the launch of emerging acute…

AllerganBotoxCoLucidGenericsGloballasmiditanLevadexMAP PharmaceuticalsMarkets & MarketingPharmaceuticalResearch

Generics and biosimilars will lead to decline in colorectal cancer market from $8.3 billion in 2011 to $7.8 billion in 2021

04-11-2012

Through 2021, growth in the market for colorectal cancer (CRC) treatments will decline in the face of…

BiotechnologyGenericsGlobalMarkets & MarketingOncology

1 to 25 of 61 results

Back to top